SynAct Pharma AB (STO:SYNACT)
Sweden
· Delayed Price · Currency is SEK 17.86
-0.76 (-4.08%)
Apr 28, 2026, 5:29 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 1.00 billion as of April 28, 2026. Its market cap has increased by 12.13% in one year.
Market Cap
1.00B
Enterprise Value
947.99M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
17.86
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 1.00B, an increase of 1,468.87%. That is a compound annual growth rate of 32.42%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.05B |
| Xspray Pharma AB | 1.12B |
| Cantargia AB | 962.13M |
| Genovis AB (publ.) | 1.32B |
| Infant Bacterial Therapeutics AB | 762.48M |
| BioInvent International AB | 1.45B |
| FluoGuide | 701.39M |
| Saniona AB | 1.94B |